Skip to main content
. 2022 Sep 27;10(10):1919. doi: 10.3390/microorganisms10101919

Figure 1.

Figure 1

The Bacillus Calmette-Guérin (BCG) vaccine was originally developed to vaccinate against tuberculosis. BCG is also known to lessen the disease burden caused by non-tuberculous mycobacteria (NTM). Currently, BCG is being studied in autoimmune diseases T1D and multiple sclerosis and in neurodegenerative diseases Alzheimer’s and Parkinson’s.